Adjunctive Intra-Aortic Balloon Pump During Venovenous Extracorporeal Membrane Oxygenation for Severe Respiratory Failure With Cardiac Dysfunction: A Retrospective Cohort Study
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Evidence regarding intra-aortic balloon pump (IABP) use during venovenous extracorporeal membrane oxygenation (VV-ECMO) is limited. We examined clinical outcomes and hemodynamic trajectories in patients with severe respiratory failure and cardiac dysfunction treated with or without adjunctive IABP. Methods In this single-center retrospective cohort study, five patients who received VV-ECMO + IABP were compared with 24 patients who received VV-ECMO only (16 original controls and eight additional controls with high-dose vasopressor exposure). The primary outcome was ventilator-free days through day 28 (VFD-28). Secondary outcomes included 7-day norepinephrine-equivalent and vasoactive-inotropic score (VIS) area under the curve (AUC), 72-hour lactate AUC, renal replacement therapy (RRT), mortality, and bleeding. The main sensitivity analysis compared the five VV-ECMO + IABP patients with all eight additional controls who had a norepinephrine-equivalent dose of at least 0.5 µg/kg/min on one or more days from D0 through D7. Additional sensitivity analyses used the 16 original controls and the four additional controls who met the high-dose threshold at D0. Results The VV-ECMO + IABP group had higher baseline SOFA scores, PEEP, and D0 norepinephrine-equivalent doses than the VV-ECMO-only group. Median VFD-28 was 0.0 days (interquartile range [IQR], 0.0–6.9) versus 0.7 days (IQR, 0.0–9.9; P = 0.740; rank-biserial correlation, − 0.10; 95% CI, − 0.54 to 0.41). Norepinephrine-equivalent AUC was 0.89 versus 0.76 (µg/kg/min)·day ( P = 0.600), VIS AUC was 89.2 versus 68.8 score·days ( P = 0.780), and verified 28-day mortality was 40.0% versus 37.5% ( P = 1.000). RRT duration was 5.0 versus 1.0 days ( P = 0.041), and recorded bleeding occurred in 80.0% versus 37.5% of patients ( P = 0.144). In the 5-vs-8 sensitivity analysis, VFD-28 was 0.0 versus 0.0 days ( P = 1.000), norepinephrine-equivalent AUC was 0.89 versus 2.01 (µg/kg/min)·day ( P = 0.268), and verified 28-day mortality was 40.0% versus 37.5% ( P = 1.000). Conclusions In this small retrospective cohort, adjunctive IABP during VV-ECMO was not associated with higher VFD-28, lower cumulative vasoactive exposure, or lower 28-day mortality. These findings require confirmation in studies with prospective cardiac phenotyping and larger samples.
Source: Research Square
Institution: Southern Medical University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: intra-aortic balloon pump, veno-venous extracorporeal membrane oxygenation, mechanical circulatory support, severe respiratory failure, cardiac dysfunction, vasoactive-inotropic score, renal replacement therapy, 28-day mortality, hemodynamic outcomes, weaning from mechanical ventilation, vasopressor-free days, sepsis
Open Access status: green
Funder: Southern Medical University
OpenAlex ID: W7236584380
